Impaired fMRI activation in patients with primary brain tumors.
about
The role of functional imaging in the tumor patientThe effects of antiepileptic drugs on cognitive functional magnetic resonance imagingBrain Tumors: The Influence of Tumor Type and Routine MR Imaging Characteristics at BOLD Functional MR Imaging in the Primary Motor Gyrus.Functional Magnetic Resonance Imaging for Preoperative Planning in Brain Tumour Surgery.Cerebrovascular reactivity mapping in patients with low grade gliomas undergoing presurgical sensorimotor mapping with BOLD fMRINeurosurgery for brain tumors: update on recent technical advances.Pathophysiological interference with neurovascular coupling - when imaging based on hemoglobin might go blind.Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumorsClinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas.Motor deficits correlate with resting state motor network connectivity in patients with brain tumours.Influence of Vascular Variant of the Posterior Cerebral Artery (PCA) on Cerebral Blood Flow, Vascular Response to CO2 and Static Functional ConnectivityThe impact of high grade glial neoplasms on human cortical electrophysiologyThe Resting-State Functional Magnetic Resonance Imaging Regional Homogeneity Metrics-Kendall's Coefficient of Concordance-Regional Homogeneity and Coherence-Regional Homogeneity-Are Valid Indicators of Tumor-Related Neurovascular Uncoupling.High-speed real-time resting-state FMRI using multi-slab echo-volumar imagingComparison of CO2 in air versus carbogen for the measurement of cerebrovascular reactivity with magnetic resonance imagingGlioblastoma Induces Vascular Dysregulation in Nonenhancing Peritumoral Regions in HumansA review of orbital and intracranial magnetic resonance imaging in 79 canine and 13 feline patients (2004-2010).Effectiveness of four different clinical fMRI paradigms for preoperative regional determination of language lateralization in patients with brain tumors.Value of Frequency Domain Resting-State Functional Magnetic Resonance Imaging Metrics Amplitude of Low-Frequency Fluctuation and Functional Amplitude of Low-Frequency Fluctuation in the Assessment of Brain Tumor-Induced Neurovascular Uncoupling.Normalization of cerebral vasoreactivity using BOLD MRI after intravascular stenting.Alteration of long-distance functional connectivity and network topology in patients with supratentorial gliomas.Neurovascular uncoupling in resting state fMRI demonstrated in patients with primary brain gliomas.Demonstration of Brain Tumor-Induced Neurovascular Uncoupling in Resting-State fMRI at Ultrahigh Field.Re-examine tumor-induced alterations in hemodynamic responses of BOLD fMRI: implications in presurgical brain mapping.Levodopa does not change cerebral vasoreactivity in Parkinson's disease.Resting state fMRI feature-based cerebral glioma grading by support vector machine.Local Glioma Cells Are Associated with Vascular Dysregulation.Limitations of Resting-State Functional MR Imaging in the Setting of Focal Brain Lesions.Task and task-free FMRI reproducibility comparison for motor network identification.Functional arterial spin labeling: Optimal sequence duration for motor activation mapping in clinical practice.Reduced CMRO₂ and cerebrovascular reserve in patients with severe intracranial arterial stenosis: a combined multiparametric qBOLD oxygenation and BOLD fMRI study.Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.Brain tumors disrupt the resting-state connectome.
P2860
Q26998680-893C14D2-E997-4DCD-8810-64DDE9609D51Q27005706-AC986698-C3F0-4075-812E-96CC9385691CQ31112813-B5D9A8C1-4004-45B8-AC9C-8CA970926E03Q31150618-ECB28297-4BB1-4F1C-AB44-CF3CE74599D5Q33563593-D1491A67-F227-49CC-B940-F41D0B472C5CQ33822509-99B960E6-C9E0-4033-9A9D-649A4D1457A5Q34201699-A68572BA-15F1-4FA5-A8D6-FFA7892D7375Q34499649-A9309BF5-DA64-421A-B643-4D204196A31FQ35607009-CE9FCDAF-64CF-44C4-B767-1F281A51AC31Q35888660-08D9B4B4-7EC2-404E-97CF-3EBDE1801E50Q36105798-5CB0ACDF-C304-422C-8865-6F40E847F320Q36314875-550D1943-50ED-4818-8294-72E3B74E3996Q36330420-C9B331E6-D6E4-47E9-8426-7F537FF29330Q37118722-C356BD41-6070-4BF7-9AFE-28921B5159D7Q37298292-54DB5231-4585-4FBF-B7EA-C42485F2F3FAQ37585900-48D15F43-B3F3-484A-A02B-ECBD96446BE6Q37898179-302A8C45-F558-476C-BF39-8A4FC86234A6Q38468810-E50CD81D-4D46-446B-813D-99634B004959Q38705302-D73B79EA-516C-4EAF-AA4E-1DABAF08CA16Q39464173-1765EF17-053E-4B9D-8D54-AEA46FDE19AAQ40243815-03C6EF6E-7C3B-4053-AB37-48A36964A6FFQ40707493-24EE06E7-9278-449B-9F81-EFAC77F81FB7Q41850681-A7C79CF2-2C41-4D16-9086-1163A45224C4Q44095668-9EF6D5D4-A04A-483D-974A-B5BAE529FC9AQ45762726-E6567B21-F4D5-43E5-B27A-18C580C51C1DQ47436092-A3D0370F-86CB-42F3-9495-7ACEAA221038Q47839222-FC0F063E-3BFC-4447-94E1-76D1C15D32C4Q47911560-C6C99B2F-869A-49D6-821A-09323EBCE268Q48372569-A25DF0EC-29FF-47EC-B897-8AFA38E5DB96Q48397308-2478B3F0-9ECD-4E0D-8275-312707642452Q48488458-763ADFD1-01C5-4863-85F2-0EDB3E889B3AQ48635940-5A5275D4-47F1-4A22-8B87-C4354397BD34Q55266169-CA8BBDCD-3ACE-4AB6-BA15-8DD9A3830B9B
P2860
Impaired fMRI activation in patients with primary brain tumors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Impaired fMRI activation in patients with primary brain tumors.
@en
Impaired fMRI activation in patients with primary brain tumors.
@nl
type
label
Impaired fMRI activation in patients with primary brain tumors.
@en
Impaired fMRI activation in patients with primary brain tumors.
@nl
prefLabel
Impaired fMRI activation in patients with primary brain tumors.
@en
Impaired fMRI activation in patients with primary brain tumors.
@nl
P2093
P50
P1433
P1476
Impaired fMRI activation in patients with primary brain tumors.
@en
P2093
Alexandre Krainik
Caroline Pasteris
Caroline Salon
Christoph Segebarth
Dominique Hoffmann
Eduardo Ramos Bombìn
Emmanuel Gay
François Berger
Irène Troprès
Jan Warnking
P304
P356
10.1016/J.NEUROIMAGE.2010.04.194
P407
P577
2010-05-08T00:00:00Z